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The human T cell-associated serine proteinase-1 (HuTSP-1) is expressed by activated T lymphocytes and is exocytosed upon their interaction with 
target cells. Here, we report that HuTSP-1 is able to convert single-chain human pro-urokinase into the active two-chain enzyme. Time-dependent 
activation by HuTSP-1 of recombinant human pro-urokinase as well as natural pro-urokinase derived from human melanoma cells was demonstrat- 
ed in a chromogenic assay specific for active urokinase type plasminogen activator and in immunoblotting experiments revealing the conversion 
of single-chain into two-chain urokinase. Control experiments excluded plasmin as the activating agent. These data suggest a novel pathway for 
plasmin generation during T cell-mediated processes uch as immune responses and extravasation of immune cells. 
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1. INTRODUCTION 
PAS catalyze the proteolytic activation of the proen- 
zyme plasminogen to plasmin, a trypsin-like proteinase 
of broad specificity. The substrate for PAS, 
plasminogen, is synthesized in the liver and is present 
in all body fluids constituting a source for the genera- 
tion of extracellular proteolysis via cellular secretion of 
PAS (for a review, see [l]). Two types of human PAS 
have been identified, which are produced by a variety 
of cells: uPA and tPA. Although both enzymes are 
evolutionarily related, they are immunologically 
distinct and are encoded by two independent genes 
[2,3]. Moreover, they seem to have different biological 
functions, as tPA is mainly responsible for fibrin clot 
lysis, whereas uPA was found to be associated with 
processes involving cell migration and tissue degrada- 
tion including inflammatory reactions [4] as well as 
tumor cell invasion [5,6] and metastasis [7,8]. In 
general, cells secrete uPA as an inactive single-chain 
proenzyme (pro-uPA) [9,10] exhibiting only 4-6070 of 
the plasminogen activating activity of two-chain uPA 
[ 111. Efficient plasminogen activation requires the con- 
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version of pro-uPA into active uPA by limited pro- 
teolysis, that can be exerted by plasmin [12], plasma 
kallikrein, or trypsin [13]. Moreover, it is assumed that 
as yet unidentified cellular proteinases are able to 
catalyze pro-uPA activation as well [15]. On the other 
hand, it has been shown that pro-uPA is proteolytically 
inactivated by thrombin or leukocyte elastase [13,14]. 
Human CD 4+ and CD 8+ T lymphocyte lines express 
a disulfide-linked homodimeric serine proteinase term- 
ed HuTSP-1 [la]. HuTSP-1 (molecular mass, 50 kDa) 
is expressed in activated, but not in resting T lym- 
phocytes in vitro and in vivo 116,171. The enzyme is 
confined to cytoplasmic storage granules, the contents 
of which are released into the extracellular space upon 
antigen binding to the T3/Ti T cell receptor complex. 
By using defined peptide substrates, HuTSP-1 was 
found to have trypsin-like specificity [ 16,181. 
Here, we report that HuTSP-1 is able to catalyze the 
conversion of human pro-uPA into active uPA. Thus, 
T cell-associated serine proteinases are candidates to 
trigger the enzymatic cascade of plasminogen activa- 
tion, which could be relevant during the generation of 
immune reactions as well as for the invasiveness of ac- 
tivated or malignant T lymphocytes. 
2. MATERIALS AND METHODS 
Rpro-uPA (231260 IU/mg; more than 93% pure, containing less 
than 0.4% active uPA) was a generous gift from Grtlnenthal 
(Stolberg, FRG). Human plasmin (P 4895, 3.3 units/mg) and 
aprotinin were obtained from Sigma (St. Louis, USA), the 
chromogenic substrates S-2444 (Glu-Gly-Arg-NH-p-nitroanilide x 
HCI), S-2251 (H-D-Val-Leu-Lys-NH-p-nitroanilide x 2 HCI), and 
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S-2288 (H-D-IIe-Pro-Arg-NH-p-nitroanilide x 2 HCI) from Kabi 
(Molndal, Sweden). Rabbit anti-human plasminogen IgG was pur- 
chased from Behring (Marburg, FRG) and goat anti-rabbit IgG con- 
jugated with alkaline phosphatase from Dianova (Hamburg, FRG). 
The human melanoma cell line Mel-Juso [19] secreting uPA was 
cuhured in RPM1 1640 supplemented with IOcrlo fetal calf serum in a 
humid atmosphere in 5% COz. Conditioned medium containing pro- 
uPA was prepared by seeding the cells at a density of 2 x lo5 cells/ml 
in RPM1 one day before adding the serum-free HL-1 medium (Paesel 
and Lorei, Frankfurt, FRG). One day thereafter the supernatants 
were harvested containing uPA (95% pro-uPA, 5010 active UPA), the 
total activation of which resulted in 30-50 IU/ml uPA activity. 
HuTSP-1 was purified from the Cd 8+ T lymphocyte clone UA 
B34.C7. The enzyme content of these cells is about 70 units 
HuTSP-i/IO6 cells [16]. One unit is defined as the amount of enzyme 
producing a AE.wt, of 0.01/h incubation at 37°C using the 
chromogenic substrate S-2288. Purification of HuTSP-I was per- 
formed as previously described [lS]. Briefly, cells were lysed at a cell 
density of 5 x lO’/ml in 10 mM Tris-HCl (pH 7.5) containing 0.1% 
(v/v) Triton X-100. After 1 h on ice, Iysates were centrifuged at 3ooO 
x g to remove particulate material, adjusted to 1 mg/mI heparin and 
applied to a p-aminobenzamidine Sepharose column (Pharmacia, 
Uppsala, Sweden), equilibrated with 0.1 M Tris-HCl (pH 8.0) con- 
taining 1 mg/ml heparin (buffer A). IrreIevant protein was removed 
from the column with a linear salt gradient ranging from 0 to 1 M 
sodium chloride in buffer A. HuTSP-1 was eluted with f M arginine- 
HCI in buffer A. By SDS-PAGE under non-reducing or reducing 
conditions and silver staining, the eluate appeared as a single protein 
band incorporating [‘H]diisopropyl fluorophosphate and migrating 
according to a molecular mass of 50000 or 25000, respectively. 
Amino acid analysis further demonstrated that HuTSP-1 is a 
homodimeric molecule [18]. The specific activity of this enzyme 
preparation was 14 100 units/mg protein. 
Pro-uPA in Mel-Juso culture supernatant (30-50 IU/ml HL-1 
medium) or rpro-uPA (100 IUiml50 mM Tris-HCl, pH 8.5, contain- 
ing 38 mM sodium chloride) were activated by addition of HuTSP-1 
or plasmin followed by incubation at 37°C. The reaction was stopped 
by addition of aprotinin (100 KIU/ml) and then active uPA was 
quantified with the chromogenic substrate S-2444 [ZO]. 
Plasmin activity in aliquots of 60 ~1 was determined by addition of 
20 gl of 30 mM Tris-HCl, pH 7.4, containing 60 mM sodium 
chloride and 20 11 of the plasmin substrate S-2251 (2 mg/ml in the 
same buffer). 
The ELISA for plasminogen/plasmin was performed using 
polyclonal rabbit anti-plasminogen IgG as primary (‘catching’) an- 
tibody and a monoclonal antibody specific for plasminogen/plasmin 
as detecting antibody [21]. 
3. RESULTS 
Pro-uPA or rpro-uPA were incubated with 
HuTSP-1. Activation of pro-uPA and rpro-uPA was 
tested in a chromogenic assay using the uPA-specific 
substrate S-2444, which was not cleaved significantly 
by pro-uPA or HuTSP-1. Fig.lA shows time- 
dependent generation of active uPA by HuTSP-1 in 
both pro-uPA preparations. After 24 h 29.6 IU/ml 
rpro-uPA or 56% of the melanoma cell-derived pro- 
uPA, respectively, were activated by 1 unit/ml 
HuTSP-1. The amount of HuTSP-1 used for the ex- 
periment (1 unit) is secreted by about 3 x lo5 activated 
UA B34.C7 cells per day [16]. 
The HuTSP- 1 -catalyzed conversion of single-chain 
rpro-uPA into active two-chain uPA was also 
demonstrated in immunoblotting experiments revealing 
142 
10 
0 
- A 
I I I I I I I 
0 1 2 3 4 5 6 
B -HuTSP 
0’. _ , 
;.I _ i. 
_ 
0 1.5 6 
Activation time thl 
0 1.5 6 
Activation time [hl 
Fig. 1. Pro-uPA activation by HuTSP. (A) Melanoma-derived human 
pro-uPA (30-50 IUlml Mel-Juso culture supernatant) (0, m) or 
Pro-uPA (100 IU/ml) (o,o) were incubated at 37°C with (filled 
symbols) or without (open symbols) HuTSP-1 (1 unit/ml) and the 
generated active uPA was quantified using the chromogenic substrate 
S-2444. (B) Rpro-uPA (100 IU/ml) was incubated at 37°C with 
HuTSP (1 unit/ml). Aliquots of 100 /tl containing about 43 ng rpro- 
uPA and 7 ng HuTSP-1 were applied to SDS-PAGE under reducing 
conditions 1231 in 7%15% polyacrylamide gradients followed by the 
electrophoretic transfer of the proteins onto nitrocellulose filters. 
Protein bands related to uPA were visualized by immunoblotting 
using rabbit anti-hump uPA IgG ~lO~g/mI) and goat anti-rabbit 
IgG coupled to alkaline phosphatase (1: 10000). 
the appearance of the heavy and light chain of active 
uPA (fig. 1B). 
In order to exclude a contamination of the HuTSP-1 
preparation with trace amounts of plasmin, a known 
activating agent of pro-uPA, we determined the 
amount of plasmin required to convert a proportion of 
pro-uPA into active uPA similar to that activated by 
the HuTSP-1 preparation. At a concentration of =2 X 
10e4 units/m~, plasmin (0.7 nMn) was found to be func- 
tionally equivalent to the HuTSP-1 preparation 
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Table 1 
Demonstration of the absence of plasmin in the HuTSP preparation 
Pro-uPA Plasmin Plasmin 
activation activity antigen 
(%/h)a (A&5/24 h)b (AE&5 min)’ 
HuTSP (1.4 units/ml) 4.1 n.d.d n.d. 
Plasmin (low4 units/ml) 2.2 0.020 0.165 
(3 X 10m4 units/ml) 5.9 :0.092 0.526 
a The generation of active uPA in Mel-Juso culture supernatant was 
quantified by incubation at 37°C with the chromogenic substrate 
S-2444 and expressed as percent of total activatable pro-uPA 
b Determined by incubation at 37°C with the chromogenic substrate 
s-2251 
’ Determined in an ELISA assay for plasmin 
d Not detectable 
(1.7 nM) and was easily detectable either in a 
chromogenic assay using the plasmin substrate S-2251 
or in an ELISA assay using antibodies specific for 
plasmin (table 1). On the other hand, no plasmin could 
be detected in the HuTSP-1 preparation using either 
assay system, demonstrating that the activation of pro- 
uPA by the HuTSP-1 preparation is not catalyzed by 
contaminating plasmin. 
4. DISCUSSION 
Initiation of the proteolytic cascade of plasminogen 
activation requires enzymatically active PAS, which are 
generated from its inactive single-chain proenzyme by 
limited proteolysis [9,10]. Up to now, humoral serine 
proteinases such as plasmin or kallikrein have been 
found to catalyze pro-uPA activation [ 12,131. Here, we 
demonstrated that HuTSP-1, a serine proteinase 
associated with T effector cells of both subsets CD 4+ 
and CD 8+ [ 161, is also able to process natural as well 
as recombinant human pro-uPA to yield the en- 
zymatically active two-chain uPA. On a molar basis the 
efficiency of the activation process catalyzed by 
HuTSP-1 or plasmin is in the same order of magnitude 
(table 1). Contaminating plasmin as the activating prin- 
ciple in the HuTSP-1 preparation was excluded. 
HuTSP-1 is selectively expressed in activated T cells. 
The enzyme, which has also been demonstrated in in- 
flammatory foci in vivo [17], is contained within in- 
tracellular storage granules and secreted by vectorially 
oriented exocytosis upon interaction of T effector cells 
with appropriate target cells [16]. Under 
pathophysiological conditions, secreted HuTSP-1 may 
thus induce the generation of both uPA and plasmin by 
activating pro-uPA, which has been found in a variety 
of tissues and cells, including those participating in in- 
flammatory reactions such as macrophages [4]. In addi- 
tion to processing plasminogen, active uPA is also 
mitogenic for T lymphocytes [22], suggesting that ac- 
tivation of pro-uPA via HuTSP-1 might contribute to 
the process of chronic inflammation by perpetuating 
destruction of extracellular tissue components as well 
as cellular proliferation. 
Recently, the extracellular prevalence of two-chain 
uPA has been demonstrated in leukemic cells of various 
lymphoid phenotype [15]. On the other hand, inactive 
single-chain uPA was predominant in tumor cells deriv- 
ed from solid tumors. On the basis of the results 
reported here, it could be speculated that T cell 
leukemias may activate newly synthesized pro-uPA by 
endogenously produced and secreted HuTSP-1, 
thereby increasing their invasive potential. Future 
studies will focus on the putative coexpression of 
HuTSP-1 and pro-uPA by malignant T lymphocytes 
and their role in extracellular proteolysis during inva- 
sion and metastasis. 
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